Vowst capsule 12S
Ended Awarded Last action
- Contract number
- SPE2DR26FSME7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,443
Award facts
- Contract value 100% obligated
- $13,443.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $13,443.47 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for VOWST Capsule 12S. The award, issued on December 9, 2025, with an ultimate completion date of December 31, 2025, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform the work at its Park Ridge, Illinois location, with no identified subcontractors involved in the delivery order.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, establishing DMS Pharmaceutical Group as a critical regional prime vendor for the Department of Defense pharmaceutical supply chain. The company's extensive product portfolio encompasses branded and generic pharmaceuticals, biologics, vaccines, and medical consumables designed to support military healthcare facilities globally, with this specific delivery order representing one of numerous orders issued to the contractor since October 2025.
Quick answers
Who was awarded contract SPE2DR26FSME7?
SPE2DR26FSME7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FSME7 worth?
The government has obligated $13,443 on SPE2DR26FSME7.
Is contract SPE2DR26FSME7 an order under another contract?
Yes. SPE2DR26FSME7 is a delivery order under SPE2DR25D9320, an indefinite delivery contract.
Was contract SPE2DR26FSME7 competed?
The extent of competition for SPE2DR26FSME7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award